Isbn: 9780826184412 - handbook of hematologic malignancies (3 Ergebnisse)

ISBN: 
Mit der Detailsuche verfeinern

Optimieren Sie Ihre Suche

  • Bücher (3)

bis

Benutzerdefinierte Preisspanne (EUR)

bis

  • Sprache: Englisch

    Verlag: Demos Medical, 2025

    0826184413 / 9780826184412

    • Softcover

    Anbieter: Books From California, Simi Valley, CA, USABooks From California

    Verkäufer/-in mit 4 Sternen
    Verkäufer/-in kontaktieren

    Zustand: Gebraucht - Gut

    EUR 51,03

    EUR 4,43 Versand 
    Versand innerhalb von USA

    Anzahl: 1 verfügbar

    paperback. Zustand: Very Good. The copy shows minor external wear, but is in otherwise clean condition.

  • Sprache: Englisch

    Verlag: Demos Medical Pub, 2025

    0826184413 / 9780826184412

    • Softcover

    Anbieter: Revaluation Books, Exeter, Vereinigtes KönigreichRevaluation Books

    Verkäufer/-in mit 5 Sternen
    Verkäufer/-in kontaktieren

    Zustand: Neu

    EUR 139,51

    EUR 14,71 Versand 
    Versand von Vereinigtes Königreich nach USA

    Anzahl: 2 verfügbar

    Paperback. Zustand: Brand New. 3rd new edition. 660 pages. 8.00x5.00x8.00 inches. In Stock.

  • Sprache: Englisch

    Verlag: Springer Publishing Company Jun 2025, 2025

    0826184413 / 9780826184412

    • Softcover

    Anbieter: AHA-BUCH GmbH, Einbeck, DeutschlandAHA-BUCH GmbH

    Verkäufer/-in mit 5 Sternen
    Verkäufer/-in kontaktieren

    Zustand: Neu

    EUR 144,72

    EUR 35,00 Versand 
    Versand von Deutschland nach USA

    Anzahl: 2 verfügbar

    Taschenbuch. Zustand: Neu. Neuware - Handbook of Hematologic Malignancies 3rd Edition remains an indispensable resource for busy hematologists, hematologic oncologists, hematopathologists, oncology advanced practice providers, oncology nurses, and trainees. This significantly revised and completely updated edition is meticulously organized to provide concise, essential information on diagnosis, prognosis, therapeutic management, and clinical trial opportunities for each hematologic malignancy. Each chapter features detailed figures that illustrate the hematopathologic characteristics of diseases, along with tables designed to simplify the review of differential diagnoses, prognostic scoring systems, molecular profiles, and therapeutic options.With over 35 new FDA-approved indications since the second edition-featuring groundbreaking advancements such as CAR-T therapy-this handbook serves as a quick reference for practice-changing information on complex diagnostic dilemmas, frontline treatments, refractory scenarios, and relapse management. Purchase includes online access via most mobile devices or computers.Key Features:- New chapters on precursor states in myeloid malignancies (CHIP/CCUS), familial/inherited risks of hematologic malignancies, CAR-T versus Bispecific Treatment, and mechanisms of CAR-T resistance.- Entirely new board-style questions, enhancing critical thinking and knowledge application with every clinical chapter.- Features updated chapters that concisely outline new standards of care and management considerations, accompanied by key references for further reading.- Highlights essential diagnostic tools, including updated 2022 WHO and ICC classification systems, that aid in conducting critical differential diagnoses and resolving complex diagnostic dilemmas.- Delivers key updates on potential practice-changing clinical trials and paradigm-shifting treatment considerations within each disease-based chapter, ensuring clinicians stay at the forefront of hematologic oncology.…